Diabetes, Nutrition and endocrinological diseases
PRINCIPAL INVESTIGATORS
- Montserrat Nacher Garcia
- Elisabet Estil·Les Altimiras
- Lydia Escolano Soriano
- Nuria Vilarrasa García
- Nuria Virgili Casas
- Manuel Pérez Maraver
- Patricia San José Terrón
CLINICAL RESEARCHERS
- Macarena Lopez Vazquez
- Jorge Caballero Corchuelo
- Laura Hernández Montoliu
- Fernando Guerrero Pérez
- Rafael López Urdiales
POSTDOCTORAL RESEARCHERS
- Claudia Fernandez Alegre
PREDOCTORAL RESEARCHERS
- Daniel Soriano Medrano
- Kevin Andrés Rivera Loor
SCIENTIFIC SUPPORT
- Marta Campos Gil
- Marina Prieto Rosales
- María Ferrés I Prat
MANAGEMENT SUPPORT
- Maria Isabel Ramis Juan
Translational Medicine
Diabetes and Metabolism
Scientific production
20
PAPERS
Average IF: 5,28
8
LED PAPER
Average IF: 3,16
5 PUBLICATIONS IN FIRST DECILE
12 PUBLICATIONS IN FIRST QUARTILE
16 PUBLICATIONS IN OPEN ACCESS
Selected publications
- Valdecantos,MP;Ruiz,L;Folgueira,C;Rada,P;Gomez Santos,B;Solas,M;Hitos,AB et al, The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk, Nat Commun, 2024;15(1):10342-10342, doi:10.1038/s41467-024-54080-w
- Sabadell Basallote,J;Astiarraga,B;Castaño,C;Ejarque,M;Repollés Dalmau,M;Quesada,I;Blanco,J et al, SUCNR1 regulates insulin secretion and glucose elevates the succinate response in people with prediabetes, J Clin Invest, 2024;134(12):doi:10.1172/JCI173214
- Ramos Rodríguez,M;Subírana Granés,M;Norris,R;Sordi,V;Fernández,A;Fuentes Páez,G;Pérez González,B et al, Implications of noncoding regulatory functions in the development of insulinomas, Cell Genom, 2024;4(8):100604-100604, doi:10.1016/j.xgen.2024.100604
- de Brachène,AC;Alvelos,MI;Szymczak,F;Zimath,PL;Castela,A;de Souza,BM;Rivada,AR et al, Interferons are key cytokines acting on pancreatic islets in type 1 diabetes, Diabetologia, 2024;67(5):908-927, doi:10.1007/s00125-024-06106-7
- Miralles Lluma,L;Vilarrasa,N;Monasterio,C;Lopez Padros,C;Alves,C;Planas,R;Arribas,L et al, Effects of a One-Year Intensified Weight Loss Program on Body Composition Parameters in Patients with Severe Obesity and Obstructive Sleep Apnea (OSA): A Randomized Controlled Trial, Nutrients, 2024;16(24):doi:10.3390/nu16244255
Research highlights
PROJECTS
4 Ongoing competitive projects
6 Started clinical trials
13 Ongoing clinical trials
NETWORKS
CIBERDEM
AGAUR SGR GRC
Selected projects
- PI19/00246. Role of ß-cell dedifferentiation in human islets failure and contribution of endoplasmic reticulum stress and mitochondrial dysfunction. Instituto de Salud Carlos III (ISCIII). Budget: 288.282,5€. 2020-2025. PI: Montanya Mias, Eduard.
- PI22/01773. Factores pronósticos y predictores de remisión de diabetes en técnicas de cirugía bariátrica hipoabsortivas: Estudio aleatorizado comparando Cruce Duodenal, SADI-S y Minigastric Bypass.. Instituto de Salud Carlos III (ISCIII). Budget: 251.680€. 2023-2025. PI: Vilarrasa García, Nuria.
- PI22/00334. Plasticidad de la masa celular beta en la obesidad y la diabetes tipo 2: papel de las células ductales pancreáticas. Instituto de Salud Carlos III (ISCIII). Budget: 147.620€. 2023-2025. PI: Montanya Mias, Eduard.
- TED-R13-002 (SHI-TED-2017-01). REGISTRO PROSPECTIVO Y MULTICÉNTRICO DE PACIENTES CON SÍNDROME DEL INTESTINO CORTO. Takeda Pharmaceuticals International AG. Budget: 69.629€. 2018- . PI: Rafael López Urdiales.
- 2017-003619-20. Efectos de Semaglutida a largo plazo en la Retinopatía Diabetica en sujetos con Diabetes Tipo 2 (FOCUS).. Novo Nordisk Pharma S.A.. Budget: 96.296€. 2019- . PI: Eduard Montanya Mias.